Jennison Associates
GHDX

Jennison Associates’s Genomic Health, Inc. GHDX Stock Holding History

Jennison Associates’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,322
Closed -$971K – 702
2019
Q3 		$971K Buy
14,322
+596
+4% +$40.9K ﹤0.01% 552
2019
Q2 		$798K Buy
13,726
+738
+6% +$43.7K ﹤0.01% 583
2019
Q1 		$910K Buy
+12,988
New +$963K ﹤0.01% 555

Jennison Associates's GHDX Position: Q4 2019 in Review

Jennison Associates sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 14,322 shares — an estimated $971K sold.

Jennison Associates first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $971K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Jennison Associates reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Jennison Associates sold 14,322 Genomic Health, Inc. shares in Q4 2019, an estimated $971K.
  • Jennison Associates first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
  • Jennison Associates's Genomic Health, Inc. position peaked at $971K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Jennison Associates's 13F filing for Q4 2019, filed 7 Feb 2020.